Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
May 5, 2017 – The FDA announced the approval of Mitsubishi Tanabe Pharma Corporation’s Radicava (edaravone) injection for the treatment of amyotrophic lateral sclerosis (ALS).
